Certified Advisory Corp Abbott Laboratories Transaction History

Certified Advisory Corp

$910 Million
Q4 2024

A detailed history of Certified Advisory Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Certified Advisory Corp holds 5,713 shares of ABT stock, worth $729,207. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,713

Previous 5,725 0.21%

Holding current value

$729,207

Previous $652,000 0.92%

% of portfolio

0.07%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$111.93 - $119.39 $1,343 - $1,432	-12 Reduced 0.21%	5,713 $646,000
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $26,518 - $31,304	-265 Reduced 4.42%	5,725 $652,000
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $603,372 - $673,515	5,990 New	5,990 $622,000
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $547,543 - $670,238	6,071 New	6,071 $668,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $8,233 - $9,690	-85 Reduced 1.41%	5,956 $603,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $8,080 - $9,479	85 Added 1.43%	6,041 $663,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $18,674 - $21,621	193 Added 3.35%	5,956 $576,000
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $58,179 - $70,320	-570 Reduced 9.0%	5,763 $626,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1,368 - $1,668	12 Added 0.19%	6,333 $750,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $52,566 - $64,364	455 Added 7.76%	6,321 $890,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $3,849 - $4,258	33 Added 0.57%	5,866 $693,000
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1,481 - $1,743	14 Added 0.24%	5,833 $676,000
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $78,909 - $92,966	725 Added 14.23%	5,819 $697,000
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $96,248 - $123,186	1,257 Added 32.76%	5,094 $466,000
Q1 2020 Apr 27, 2020	SELL	$62.82 - $91.86 $8,983 - $13,135	-143 Reduced 3.59%	3,837 $303,000
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $549 - $611	7 Added 0.18%	3,980 $346,000
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $53,768 - $58,302	657 Added 19.81%	3,973 $332,000
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $583 - $680	8 Added 0.24%	3,316 $279,000
Q1 2019 May 07, 2019	BUY	$66.22 - $80.06 $44,234 - $53,480	668 Added 25.3%	3,308 $264,000
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $5,441 - $6,164	83 Added 3.25%	2,640 $191,000
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $5,594 - $6,749	-92 Reduced 3.47%	2,557 $188,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $6,275 - $6,925	109 Added 4.29%	2,649 $155,000
Q1 2018 Apr 30, 2018	BUY	$56.27 - $63.62 $506 - $572	9 Added 0.36%	2,540 $152,000
Q4 2017 Feb 22, 2018	BUY	$53.68 - $57.47 $135,864 - $145,456	2,531	2,531 $144,000

Others Institutions Holding ABT

# of Institutions

3,375

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.

Account

Certified Advisory Corp Abbott Laboratories Transaction History